← Eichor
Condition: Myositis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Myositis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases
Phase 1 · 1 location(s) · Xencor, Inc. · NCT07284797Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry
Phase N/A · 9 location(s) · Peking Union Medical College Hospital · NCT06417502Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis
EARLY_Phase 1 · 2 location(s) · Austin Neuromuscular Center · NCT06479863Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
Phase N/A · 1 location(s) · University of Bonn · NCT07150000FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)
Phase 2 · 1 location(s) · National Institute of Environmental Health Sciences (NIEHS) · NCT07111065A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Phase 1 · 14 location(s) · CRISPR Therapeutics · NCT06925542Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT06387654A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Phase 1/Phase 2 · 17 location(s) · Nkarta, Inc. · NCT06733935Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
Phase 2 · 8 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07103746Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT05251415Biomarkers in Autoimmune Disease of Nervous System
Phase N/A · 1 location(s) · Tongji Hospital · NCT06502015Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune D
NA · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT07558850Rare AutoImmune SElf-management Programme Development
Phase N/A · 1 location(s) · University of the West of England · NCT06642870Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT07184450Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis
Phase N/A · 1 location(s) · CHU de Reims · NCT06462768Intralesional Injection of STS in Treatment of Calcinosis
Phase 2 · 1 location(s) · Robyn T. Domsic, MD, MPH · NCT06672822A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflamm
Phase 1 · 5 location(s) · Nanjing Legend Biotech Co. · NCT07331272A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases
Phase 1 · 1 location(s) · China Immunotech (Beijing) Biotechnology Co., Ltd. · NCT07123519A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Phase 1 · 19 location(s) · GlaxoSmithKline · NCT07371468Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
Phase 1 · 1 location(s) · Polina Stepensky · NCT07085676CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease
Phase 1/Phase 2 · 1 location(s) · Miltenyi Biomedicine GmbH · NCT06347718A Study of AZD0120 in Autoimmune Diseases
Phase 1 · 22 location(s) · AstraZeneca · NCT07295847Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositi
Phase N/A · 1 location(s) · National Institute of Arthritis and Musculoskeletal and Skin · NCT00059748Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study
Phase 2 · 8 location(s) · University Hospital, Limoges · NCT03582800A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
Phase 1 · 1 location(s) · China Immunotech (Beijing) Biotechnology Co., Ltd. · NCT06978647Adult and Juvenile Myositis
Phase N/A · 4 location(s) · National Institute of Environmental Health Sciences (NIEHS) · NCT00017914Search for Diagnostic and Prognostic Biomarkers in Systemic Sclerosis and Inflammatory Myopathies
NA · 1 location(s) · University Hospital, Strasbourg, France · NCT04917705Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT06569472A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
Phase N/A · 1 location(s) · Kyverna Therapeutics · NCT07403188Natural History of Inflammatory Muscle Diseases
Phase N/A · 1 location(s) · National Institute of Arthritis and Musculoskeletal and Skin · NCT05738824
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.